Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing.
Annu LuostarinenAnssi KailaanmäkiVesa TurkkiMarjut KöylijärviPiia KäyhtyHanna LeinonenVita Albers-SkirdenkoEevi LipponenSeppo Ylä-HerttualaTanja KaartinenHanna P LeschTuija KekarainenPublished in: Cytotherapy (2024)
in 50 mM HEPES provided a feasible FFB to cryopreserve a VSV-G -pseudotyped LV for CAR-T-cell production. The LVs remained relatively stable for at least 24 h post-thaw, even at ambient temperatures. This study provides insights into process development, showing LV formulation data generated using the relevant target cell type for CAR-T-cell manufacturing.